Publish with JCO GO or JCO OA. Advantages of fully #OpenAccess journals include: More citations & downloads Greater engagement A wider opportunity to advance cancer care globally Compliance with funder mandates With International #OAWeek coming up, learn how you can expand your reach.

Check out the article in JCO on the Metformin Active Surveillance Trial in Low-Risk Prostate Cancer. Learn about the latest research on this common drug's potential role in managing prostate cancer: brnw.ch/21wX6DG

@councilscienceed.bsky.social (CSE) is offering our virtual Short Course on Pub Management on 10/31/25. The agenda is full of everything you need to know to make your publication the best it can be. 15% off if you also reg for the CSE Fall Symposium! www.councilscienceeditors.org/short-courses

We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.

Now available!! 🎧 Listen in to JCO OP's latest podcast, Promoting Resilience in Adolescents and Young Adults (AYAs) with Cancer via Developmentally Targeted, Evidence-Based Interventions | Podcast | ASCO Publications ascopubs.org/do/promoting...

Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries | JCO Global Oncology ascopubs.org/doi/10.1200/...

Listen to the latest JCO Oncology Practice podcast, in which @fumikochino.bsky.social discusses barriers to cancer care that seem minor (e.g. paying for park) but are definitely not. ascopubs.org/do/park-park...

Stay connected to JCO Journals during #ASCO25! www.asco.org/annual-meeti...

Stop by JCO central while at ASCO. Enjoy the coffee, meet the editors and staff, learn more about JCO

Simultaneous Publication in #JCOOP. #ASCO25 Educational Impact of a Podcast Curriculum for Hematology/Oncology Fellows: Final Results of the Multicenter Cluster Randomized PODCAST-HOF Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...

If you didn't hang out in JCO Central, did you even really attend #ASCO25? Come join us for some great events in S403b!

‼️ #ASCO25 simultaneous publication by Jacobs et al:  BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...

Read all about it! Simultaneous Publication out now in JCO: BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...

Psst ... want to see how we're brewing up #ASCO25? We're busy behind the scenes making sure everything's just right! Can't WAIT to officially open the doors, welcome everyone, and get this Annual Meeting party started! See you there!

Pregnancy and Breast Cancer | Podcast | ASCO Publications ascopubs.org/do/pregnancy...

Time to Treatment Initiation for the 30 Most Prevalent Cancer Types: Trends and Predictors of Change | JCO Oncology Practice ascopubs.org/doi/10.1200/...

Use of Large Language Models in Clinical Cancer Research | JCO Clinical Cancer Informatics ascopubs.org/doi/full/10....

📣 Have something to report on an ongoing clinical trial? #JCOOA now accepting Trials in Progress articles! Read the first one here: SWOG 2308: Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low–Tumor Burden Follicular Lymphoma ascopubs.org/doi/10.1200/...

In the latest episode of JCO OP: Put Into Practice, @fumikochino.bsky.social talks with Dr. Atif Khan and Dr. Lola Fayanju about treatment de-escalation in patients with breast cancer. ascopubs.org/do/treatment...

Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/...

This is high art

Navigating a change from self-publishing, independent publishing, or a commercial publisher can be tenuous and fraught. Join Adam Etkin and Susan Willner at 12 PM ET as we discuss how to plan for an effective publisher move! Register NOW: www.councilscienceeditors.org/cse-connect

Early Bird registration is ending soon for the @councilscienceed.bsky.social annual meeting. Join us in Minneapolis May 3-6!

Large Language Models as Decision-Making Tools in Oncology: Comparing Artificial Intelligence Suggestions and Expert Recommendations | JCO Clinical Cancer Informatics ascopubs.org/doi/10.1200/...

🎙️In the latest #JCOOP podcast, @fumikochino.bsky.social discusses the past, present, and future of prior authorization in cancer care with Dr. Michael Anne Kyle, a health policy expert with a research focus on utilization management and patient burdens from prior auth. 🎧 ascopubs.org/do/prior-aut...

Phase II Evaluation of Ultra-Hypofractionated Postoperative Radiation Therapy for Breast Cancer: Toxicity and Efficacy in a Single-Center Nonrandomized Prospective Study | JCO Global Oncology ascopubs.org/doi/10.1200/...

ICYMI: JCO Oncology Practice has a new podcast, and the second episode is here: ascopubs.org/do/optimizin... Subscribe wherever you get your podcasts! #JCOOP

Real-World Utilization and Performance of Circulating Tumor DNA Monitoring to Predict Recurrence in Solid Tumors | JCO Oncology Advances ascopubs.org/doi/10.1200/...

Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide | JCO Oncology Practice ascopubs.org/doi/10.1200/...

📻 ICYMI: The second episode of the JCO Oncology Practice: Put Into Practice podcast is now live! Listen here and subscribe wherever you get your podcasts. ascopubs.org/do/optimizin... 🎙️

Check out this infographic from #JCOCCI that accompanies the recent article, Methodologic Approach to Defining Comorbidities in a Cohort of Patients With Cancer: An Example in the Optimal Breast Cancer Chemotherapy Dosing Study. ascopubs.org/doi/10.1200/...

Let this be your soundtrack today, and Amazon Music will donate $1 for every stream to @conquercancer.bsky.social.

We welcome Dr. Katherine Van Loon as our newest Editor-in-Chief of JCO Global Oncology. Welcome Dr. Van Loon!

If you are at ASCO #GI25, you do NOT want to miss this session at 11:45 this morning, all about the process of publishing your research. Come hear from #JCO editors and network with others! @pamelakunzmd.bsky.social

Attending ASCO #GI25? Stop by the ASCO booth and hear all about the JCO Oncology Advances, the newest member of the JCO Journals! Also learn more about the new podcast from #JCOOP.

#JCOJournals are so excited about the launch of a new podcast from JCO Oncology Practice. This first episode, featuring host @fumikochino.bsky.social, is Debt or Dying: The JCO OP Financial Toxicity Special Issue. Don't miss it! ascopubs.org/do/debt-dyin...

🚨 The #FinancialToxicity special issue of JCO OP is LIVE today! 🚨 We hope these papers will encourage the next gen of researchers to generate, evaluate, & disseminate patient-centered, high-quality, evidence-based medicine & policy solutions to close the affordability gap! ascopubs.org/toc/op/21/1

Can a machine learning (ML) algorithm outperform PD-L1 as a predictive biomarker for response to first-line therapy in patients with advanced non–small cell lung cancer? New #JCOCCI pub: ascopubs.org/doi/full/10.... @emiliemgunn.bsky.social @acochran12733.bsky.social

🔔 ICYMI: Here are the top articles from JCO Journals from 2024: ascopubs.org/2024-top-art...

Oh man, I love a good pun. Especially with a publishing reference!

We have a new article in JCO CCI describing a symptom monitoring app that might help with endocrine therapy adherence; graphical abstract attached! #bcsm ascopubs.org/doi/full/10.... @acochran12733.bsky.social @drbeccak.bsky.social @emiliemgunn.bsky.social

New JCO CCI article: ascopubs.org/doi/full/10..... Jiang et al. used dynamic risk models to predict 5-year breast cancer risk in diverse populations. By using routinely collected interval imaging data, this modeling approach could enhance personalized screening strategies & early disease detection.

Automatic metastatic versus localized stage extraction from clinical trial publications just published in JCO CCI. Check it out today, and let us know your thoughts! ascopubs.org/doi/abs/10.1... @acochran12733.bsky.social @emiliemgunn.bsky.social